CA2637297A1 - Transdermal patch incorporating active agent migration barrier layer - Google Patents

Transdermal patch incorporating active agent migration barrier layer Download PDF

Info

Publication number
CA2637297A1
CA2637297A1 CA002637297A CA2637297A CA2637297A1 CA 2637297 A1 CA2637297 A1 CA 2637297A1 CA 002637297 A CA002637297 A CA 002637297A CA 2637297 A CA2637297 A CA 2637297A CA 2637297 A1 CA2637297 A1 CA 2637297A1
Authority
CA
Canada
Prior art keywords
active agent
layer
barrier layer
transdermal patch
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002637297A
Other languages
French (fr)
Other versions
CA2637297C (en
Inventor
Kenneth J. Ii Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Technologies Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2637297A1 publication Critical patent/CA2637297A1/en
Application granted granted Critical
Publication of CA2637297C publication Critical patent/CA2637297C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)

Abstract

Devices (100) for administration of one or more active agents to the skin or mucosa of a host are formed in the nature of a double-disk patch (100). One outer layer (110) functions as the primary adhesive layer for adhering the patch (100) to the host. The other inner layer (122) contains at least one active agent to be administered to the host. The inner layer (122) is bonded to the outer layer (110) through an opening (114) provided in an interposed active agent impermeable release layer (104). The release layer (104) separates a circumferential portion of the active agent containing inner layer (122) from the outer adhesive layer (220) to inhibit migration of the active agent therebetween.
CA002637297A 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer Expired - Fee Related CA2637297C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/641,654 US8524272B2 (en) 2003-08-15 2003-08-15 Transdermal patch incorporating active agent migration barrier layer
US10/641,654 2003-08-15
CA2531504A CA2531504C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2531504A Division CA2531504C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer

Publications (2)

Publication Number Publication Date
CA2637297A1 true CA2637297A1 (en) 2005-03-03
CA2637297C CA2637297C (en) 2009-07-21

Family

ID=34136410

Family Applications (6)

Application Number Title Priority Date Filing Date
CA2637321A Expired - Fee Related CA2637321C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2637849A Expired - Fee Related CA2637849C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2531504A Expired - Fee Related CA2531504C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2708347A Expired - Fee Related CA2708347C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA002637297A Expired - Fee Related CA2637297C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2638743A Expired - Fee Related CA2638743C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer

Family Applications Before (4)

Application Number Title Priority Date Filing Date
CA2637321A Expired - Fee Related CA2637321C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2637849A Expired - Fee Related CA2637849C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2531504A Expired - Fee Related CA2531504C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer
CA2708347A Expired - Fee Related CA2708347C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2638743A Expired - Fee Related CA2638743C (en) 2003-08-15 2004-01-26 Transdermal patch incorporating active agent migration barrier layer

Country Status (7)

Country Link
US (3) US8524272B2 (en)
EP (1) EP1653897A4 (en)
JP (1) JP4388068B2 (en)
AU (1) AU2004266563B2 (en)
CA (6) CA2637321C (en)
MX (1) MXPA06001783A (en)
WO (1) WO2005018517A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE333271T1 (en) * 2003-02-21 2006-08-15 Schering Ag UV-STABLE TRANSDERMAL PLASTER
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
EP1898891A2 (en) * 2005-05-13 2008-03-19 Alza Corporation Multilayer drug delivery system with barrier against antagonist exposure
DK1895994T3 (en) * 2005-05-13 2010-12-20 Alza Corp Multilayer drug delivery system with barrier against reservoir material flow
EP1928881A2 (en) 2005-08-19 2008-06-11 Pharmacofore, Inc. Prodrugs of active agents
US7955677B2 (en) * 2005-12-07 2011-06-07 Mylan Technologies, Inc. Two-sided non-stick release film
SG172633A1 (en) 2006-05-26 2011-07-28 Pharmacofore Inc Controlled release of phenolic opioids
EP2047335B1 (en) * 2006-07-25 2011-05-11 Hewlett-Packard Development Company, L.P. Methods of producing ink toners
DE102006054733A1 (en) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with high drug utilization rate and dosing accuracy
DE102007025973A1 (en) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Storage stable laminate sections
JP5394083B2 (en) 2008-02-06 2014-01-22 日東電工株式会社 Patch packaging structure
DE102011080390B3 (en) * 2011-08-03 2012-07-12 Acino Ag application aid
WO2013049387A1 (en) 2011-09-30 2013-04-04 Teikoku Pharma Usa, Inc. General medication disposal system
WO2013049380A1 (en) 2011-09-30 2013-04-04 Teikoku Pharma Usa, Inc. Transdermal patch disposal system
CN105287440A (en) * 2014-06-18 2016-02-03 杨宁正 Permeation type pharmaceutic thin film patch
US10335406B2 (en) 2015-10-01 2019-07-02 Elysium Therapeutics, Inc. Opioid compositions resistant to overdose and abuse
CA2998708C (en) 2015-10-01 2019-09-03 Elysium Therapeutics, Inc. Polysubunit opioid prodrugs resistant to overdose and abuse
US10076473B2 (en) * 2016-02-15 2018-09-18 C&Tech Corporation Apparatus and method for manufacturing dried gel sheet and gel sheet or beauty pack manufactured by the same
EP3595663A4 (en) 2017-03-17 2021-01-13 Elysium Therapeutics, Inc. Polysubunit opioid prodrugs resistant to overdose and abuse
US20190015352A1 (en) * 2017-07-14 2019-01-17 Pendleton Brewster Wickersham Applicators & Patches for Dermal & Transdermal Treatment Material & Drug Delivery, Methods of Making Them, & Methods of Use
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
USD999384S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly
USD999385S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2375861A1 (en) 1976-12-31 1978-07-28 Merieux Inst ADHESIVE PAD FOR EPICUTANE TESTS
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4725272A (en) 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
US4573996A (en) 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4601893A (en) 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4564010A (en) 1984-04-18 1986-01-14 Daubert Coated Products Inc. Pressure sensitive adhesive film for medical use
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
ES8608895A1 (en) 1984-08-17 1986-07-16 Allpack Ind Lohnverpackung Therapeutical adhesive plaster and process for its manufacture.
US4666441A (en) 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4627429A (en) 1986-02-28 1986-12-09 American Home Products Corporation Storage-stable transdermal adhesive patch
DE3775830D1 (en) 1986-06-13 1992-02-20 Alza Corp ACTIVATING A TRANSDERMAL DRUG DELIVERY SYSTEM THROUGH MOISTURE.
CH672888A5 (en) 1986-11-07 1990-01-15 Mepha Ag
US4911707A (en) 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
KR970008118B1 (en) 1987-07-09 1997-05-21 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 Transdermal therapeutic system
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4849224A (en) 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4983395A (en) 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
DE3903794A1 (en) 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts THERAPEUTIC SYSTEM FOR THE TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE SUBSTANCES AND ITS USE
US5217718A (en) 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5064422A (en) 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5123900A (en) 1991-08-16 1992-06-23 Bertek, Inc. Moisture permeable double disk
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5756117A (en) 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
US5503844A (en) 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
DE4316751C1 (en) 1993-05-19 1994-08-04 Lohmann Therapie Syst Lts Method and device for producing a transdermal therapy system for the administration of active substances to the skin in the form of a flat multi-chamber or multi-chamber channel system
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
US5783647A (en) * 1994-12-15 1998-07-21 Shin-Etsu Chemical Co., Ltd. 1,1,2,2-tetramethylpropylperoxy esters and method for preparing vinyl polymers
WO1996019205A1 (en) 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
CA2218369C (en) 1995-06-05 2010-02-09 Alza Corporation Transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6284266B1 (en) 1995-07-28 2001-09-04 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
KR100213465B1 (en) 1996-11-01 1999-08-02 최좌진 Multi-layer ketoprofen patch
US5738647A (en) 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
IL120943A (en) 1997-05-29 2004-03-28 Univ Ben Gurion Transdermal delivery system
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
DE19925613A1 (en) 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Composite laminate and process for its manufacture
WO2001095889A1 (en) 2000-06-13 2001-12-20 Hisamitsu Pharmaceutical Co., Inc. Plaster
US6471986B1 (en) 2000-07-31 2002-10-29 Schering Plough Healthcare Products, Inc. Corn, callus and wart removing pads
DE10060852A1 (en) 2000-12-06 2002-06-20 Hexal Ag Active ingredient-impermeable cover layer or removable protective layer of a transdermal therapeutic system containing absorbents and channel formers
MXPA03009603A (en) 2001-04-20 2004-12-06 Johnson & Johnson Microprojection array having a beneficial agent containing coating.
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
NZ537991A (en) 2002-08-30 2007-08-31 Alza Corp Embossable and writable multilaminate backing construction
US20040191301A1 (en) 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
CA2530531A1 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
WO2005025549A2 (en) 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device

Also Published As

Publication number Publication date
CA2638743A1 (en) 2005-03-03
US20050037059A1 (en) 2005-02-17
CA2531504C (en) 2011-04-12
US20130274694A1 (en) 2013-10-17
AU2004266563B2 (en) 2011-03-10
CA2531504A1 (en) 2005-03-03
WO2005018517A1 (en) 2005-03-03
MXPA06001783A (en) 2006-05-04
CA2638743C (en) 2012-05-22
CA2708347A1 (en) 2005-03-03
JP2007502649A (en) 2007-02-15
US8524272B2 (en) 2013-09-03
CA2637849C (en) 2010-04-13
CA2637849A1 (en) 2005-03-03
EP1653897A1 (en) 2006-05-10
AU2004266563A1 (en) 2005-03-03
CA2637297C (en) 2009-07-21
JP4388068B2 (en) 2009-12-24
CA2637321C (en) 2010-04-13
US20140249492A1 (en) 2014-09-04
US9358373B2 (en) 2016-06-07
US8802136B2 (en) 2014-08-12
EP1653897A4 (en) 2012-03-21
CA2637321A1 (en) 2005-03-03
CA2708347C (en) 2012-12-18

Similar Documents

Publication Publication Date Title
CA2637297A1 (en) Transdermal patch incorporating active agent migration barrier layer
CA2053272A1 (en) Device for administering an active agent to the skin or mucosa
WO2001026705A3 (en) A dual adhesive transdermal drug delivery system
KR890007761A (en) Apparatus for administering an effective drug to skin or mucous membranes
CA2427764A1 (en) Transdermal drug delivery system with improved water absorbability and adhesion properties
CA2453013A1 (en) Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
CN1170360A (en) Transdermal delivery system with adhesive overlay and peel seal disc
AR017026A1 (en) UNINTERRUPTED DRUG RELEASE DEVICE
CA2133598A1 (en) Non-occlusive adhesive patch for applying medication to the skin
DE69531488D1 (en) MEDICINE-CONTAINING, ADHESIVE, ASSEMBLABLE, TRANSDERMAL DISPENSER
KR20050042014A (en) Plaster having laminated support
WO2005082428A3 (en) Plaster that reduces skin irritation
WO2005025549A3 (en) Multi-layer transdermal drug delivery device
AR033748A1 (en) A DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES THAT INCLUDES TWO SUPERPOSED ADHESIVE LAYERS AND A PROCEDURE TO PREPARE IT
CA2338859A1 (en) Estradiol-containing patch for transdermal administration of hormones
JP5514823B2 (en) Iontophoresis drug delivery packaging
WO2002022109A3 (en) Patch comprising diclofenac
CA1309661C (en) Transdermal delivery system
JP2019516671A (en) Dual disc percutaneous system
KR101229667B1 (en) Topical patch preparation for treatment of toxicity of mosquitoes
WO2001026637A3 (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
CA2403949A1 (en) Transdermal therapeutic system for the delivery of lerisetron
US20140158571A1 (en) Packaging structure for patches
CA2294067C (en) Device for delivery of dermatological ingredients
WO2006002200A3 (en) Packaging for medical pads and electrodes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220126